These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
214 related items for PubMed ID: 6159081
1. Combination chemotherapy for non-small cell bronchogenic carcinoma with bleomycin, doxorubicin, methotrexate, and cis-dichlorodiammineplatinum(II) (BAMP). Vogl SE, Wollner D, Kaplan BH, Berenzweig M. Cancer Treat Rep; 1980; 64(4-5):717-9. PubMed ID: 6159081 [No Abstract] [Full Text] [Related]
2. Bleomycin, cisplatin, vincristine, and methotrexate in advanced non-small cell bronchogenic carcinoma. Rosenthal CJ, Ritter S, Platica O. Cancer Treat Rep; 1982 Jan; 66(1):205-6. PubMed ID: 6171350 [No Abstract] [Full Text] [Related]
3. Six-drug combination chemotherapy for nonresectable bronchogenic carcinoma. Miller CF, Weltz MD, Heim WJ, Blom J. Cancer Treat Rep; 1979 Aug; 63(8):1351-3. PubMed ID: 113094 [No Abstract] [Full Text] [Related]
4. [Chemotherapy of bronchopulmonary cancer. Trial of the BACON protocol]. Adenis L, Restellini J, Caty A. LARC Med; 1981 Nov; 1(2):50-1. PubMed ID: 6188012 [No Abstract] [Full Text] [Related]
5. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP) treatment of non-oat cell bronchogenic carcinoma. Vogelzang NJ, Bonomi PD, Rossof AH, Wolter J. Cancer Treat Rep; 1978 Oct; 62(10):1595-7. PubMed ID: 709563 [No Abstract] [Full Text] [Related]
6. [Comparative study of 2 different chemotherapeutic combinations in epidermoid carcinoma of the lung. Preliminary results]. Pipino G, Germiniani R, Maione G, Fazio FM. Arch Sci Med (Torino); 1983 Oct; 140(2):135-8. PubMed ID: 6192792 [No Abstract] [Full Text] [Related]
7. cis-Dichlorodiammineplatinum (II) in small cell anaplastic bronchogenic carcinoma: a phase II study. Dombernowsky P, Sörenson S, Aisner J, Hansen HH. Cancer Treat Rep; 1979 Apr; 63(4):543-5. PubMed ID: 221119 [No Abstract] [Full Text] [Related]
8. [Treatment of small-cell bronchogenic carcinoma with a combination of chemotherapy and irradiation (author's transl)]. Dundalek E. Prax Klin Pneumol; 1980 Dec; 34(12):719-23. PubMed ID: 7465532 [No Abstract] [Full Text] [Related]
9. Cis-platin, vindesine, doxorubicin and cyclophosphamide in the treatment of non-small cell bronchogenic carcinoma. Athanassiades P, Lagoudis M, Kostis E. J Chemother; 1989 Jul; 1(4 Suppl):1205-6. PubMed ID: 16312835 [No Abstract] [Full Text] [Related]
10. Combination chemotherapy for extracranial metastases of a primary malignant cerebral neoplasm. Oster MW. Cancer Treat Rep; 1979 Aug; 63(8):1417-8. PubMed ID: 476715 [Abstract] [Full Text] [Related]
11. Cyclophosphamide, doxorubicin, and cisplatin in the treatment of non-small cell bronchogenic carcinoma. Evans WK, Feld R, DeBoer G, Osoba D, Curtis JE, Baker MA, Myers RE, Quirt IC, Pritchard KI, Brown TC, Kutas GJ, Blackstein ME, Ottema B, Millband L. Cancer Treat Rep; 1981 Aug; 65(11-12):947-54. PubMed ID: 7028256 [Abstract] [Full Text] [Related]
12. Chemotherapy for inoperable, non-small cell bronchogenic carcinoma: EST 2575, generation II. Ruckdeschel JC, Mehta CR, Salazar OM, Cohen M, Vogl S, Koons LS, Lerner H. Cancer Treat Rep; 1981 Aug; 65(11-12):965-72. PubMed ID: 7028258 [Abstract] [Full Text] [Related]
13. Chemotherapy for adenocarcinoma and large cell anaplastic carcinoma of the lung with ftorafur, adriamycin, and cis-dichlorodiammineplatinum(II). Issell BF, Valdivieso M, Bodey GP. Cancer Treat Rep; 1978 Jul; 62(7):1089-91. PubMed ID: 210943 [No Abstract] [Full Text] [Related]
14. "CAMP" combination chemotherapy for unresectable non-oat cell bronchogenic carcinoma. Lad T, Sarma PR, Diekamp U, Tichler T, Chawla M, Krauss S, Zawila P, Nelson R. Cancer Clin Trials; 1979 Jul; 2(4):321-6. PubMed ID: 394868 [Abstract] [Full Text] [Related]
15. [A study of two protocols of multiple chemotherapy in small round cell tumours of the lung (author's transl)]. Israël L, Breau JL, Depierre A, Choffel C, Lemarié E, Battesti JP. Rev Fr Mal Respir; 1981 Jul; 9(2):123-31. PubMed ID: 6166970 [No Abstract] [Full Text] [Related]
16. Chemotherapy for small cell bronchogenic carcinoma: CCNU and doxorubicin compared to CCNU, doxorubicin, vincristine, and procarbazine. Vogelzang NJ, Trowbridge RC, Frenning DH, Theologides A, Kennedy BJ, Kelly DR, Ewing SL, Vosika GJ. Cancer Treat Rep; 1980 Jul; 64(8-9):997-1000. PubMed ID: 6256076 [Abstract] [Full Text] [Related]
17. [Value of polychemotherapy for bronchogenic carcinoma other than undifferentiated small cell carcinoma]. Laberge F, Desmeules M, Bergeron D, La Forge J, Cormier Y. Union Med Can; 1984 Mar; 113(3):222-4. PubMed ID: 6730096 [No Abstract] [Full Text] [Related]
18. Cisplatin combination chemotherapy in non-oat cell carcinoma of the lung. Vincent RG, Lane WW, Raza S, Madajewicz S. Cancer Treat Rep; 1982 Jan; 66(1):197-8. PubMed ID: 6975658 [No Abstract] [Full Text] [Related]
19. Chemotherapy for metastatic non-small cell bronchogenic carcinoma: EST 2575, generation III, HAM versus CAMP. Ruckdeschel JC, Mehta CR, Salazar OM, Creech RH, Sponzo RW. Cancer Treat Rep; 1981 Jan; 65(11-12):959-63. PubMed ID: 6794909 [Abstract] [Full Text] [Related]
20. cis-Dichlorodiammineplatinum(II) in non-small cell carcinoma of the lung. Gralla RJ, Cvitkovic E, Golbey RB. Cancer Treat Rep; 1979 Jan; 63(9-10):1585-8. PubMed ID: 498158 [Abstract] [Full Text] [Related] Page: [Next] [New Search]